Cabaletta Bio, Inc. (CABA)
| Market Cap | 52.45M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -49.53M |
| Shares Out | 28.98M |
| EPS (ttm) | -1.80 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 267,615 |
| Open | 1.49 |
| Previous Close | 1.49 |
| Day's Range | 1.49 - 1.85 |
| 52-Week Range | 1.17 - 14.95 |
| Beta | 1.35 |
| Analysts | Buy |
| Price Target | 15.98 (+782.9%) |
| Earnings Date | May 16, 2022 |
About CABA
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company's lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune b...
Financial Performance
Financial StatementsAnalyst Forecast
According to 13 analysts, the average rating for CABA stock is "Buy." The 12-month stock price forecast is 15.98, which is an increase of 782.87% from the latest price.
News
Cabaletta Bio Reports First Quarter 2022 Financial Results and Provides Business Update
– DesCAARTes™ trial clinical and translational data from cohorts A3 and A4 and 28-day safety data from cohort A5 expected to be presented at upcoming scientific meetings in mid-2022 –
Cabaletta Bio to Present DSG3-CAART Clinical Data and MuSK-CAART Preclinical Data at Upcoming Scientific Meetings in May
PHILADELPHIA, May 02, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery and development of targeted cell therapies for patients...
CABA LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Cabaletta Bio, Inc
New York, New York--(Newsfile Corp. - April 29, 2022) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Cabaletta Bio, Inc....
CABA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 29, 2022 in the Class Action Filed on Beh...
New York, New York--(Newsfile Corp. - April 29, 2022) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Cabaletta Bio, Inc. (NASDAQ: CABA) alleging...
Bronstein, Gewirtz & Grossman, LLC Reminds Cabaletta Bio, Inc. (CABA) Investors of Class Action Deadline and Last Few...
New York, New York--(Newsfile Corp. - April 29, 2022) - Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cabaletta Bio, Inc. ("Cabaletta" or "the ...
CABA LAWSUIT ALERT: Levi & Korsinsky Notifies Cabaletta Bio, Inc. Investors of a Class Action Lawsuit and Upcoming De...
New York, New York--(Newsfile Corp. - April 29, 2022) - Levi & Korsinsky, LLP notifies investors in Cabaletta Bio, Inc. ("Cabaletta" or the "Company") (NASDAQ: CABA) of a class action securities lawsuit...
Deadline Today Alert: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Cont...
Los Angeles, California--(Newsfile Corp. - April 29, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cabaletta Bio, Inc...
CABA SHAREHOLDER ALERT: Jakubowitz Law Reminds Cabaletta Shareholders of a Lead Plaintiff Deadline of April 29, 2022
NEW YORK, April 29, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Cabaletta Bio, Inc. (NASDAQ: CABA). To receive u...
Deadline Tomorrow Alert: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to C...
Los Angeles, California--(Newsfile Corp. - April 28, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cabaletta Bio, Inc...
FINAL DEADLINE FRIDAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secur...
New York, New York--(Newsfile Corp. - April 27, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...
Deadline Friday Reminder: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to ...
Los Angeles, California--(Newsfile Corp. - April 27, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cabaletta Bio, Inc...
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Cabaletta Bio, Inc. of a Class Action Lawsuit and a Le...
NEW YORK , April 27, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cabaletta Bio, Inc.. Shareholders who purchased shares of CABA during the class period listed ...
CABA FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses Over $100K to...
NEW YORK , April 26, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant and/or traceabl...
Friday Deadline Notice: The Schall Law Firm Encourages Investors in Cabaletta Bio, Inc. with Losses of $100,000 to Co...
Los Angeles, California--(Newsfile Corp. - April 26, 2022) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Cabaletta Bio, Inc...
CABA ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of April 29, 2022 in the Class Action Filed on Beh...
NEW YORK , April 26, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Cabaletta Bio, Inc. (NASDAQ: CABA) alleging that the Comp...
Bronstein, Gewirtz & Grossman, LLC Reminds Cabaletta Bio, Inc. (CABA) Investors of Class Action Deadline and Encourag...
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Cabaletta Bio, Inc. ("Cabaletta" or "the Company...
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Cabaletta Investors of a Lead Plaintiff Deadline of April ...
NEW YORK , April 25, 2022 /PRNewswire/ -- Attention Cabaletta Bio, Inc. ("Cabaletta") (NASDAQ: CABA) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on b...
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel B...
New York, New York--(Newsfile Corp. - April 23, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...
ROSEN, RESPECTED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors to Secure Counsel Before Important April ...
New York, New York--(Newsfile Corp. - April 21, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...
NATIONALLY RANKED ROSEN LAW FIRM Encourages Cabaletta Bio, Inc. Investors with Losses to Secure Counsel Before Import...
New York, New York--(Newsfile Corp. - April 20, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Cabaletta Bio (CABA) Investors with Significant Losses to Contact...
San Francisco, California--(Newsfile Corp. - April 19, 2022) - Hagens Berman urges Cabaletta Bio, Inc. (NASDAQ: CABA) investors who suffered significant losses to submit your losses now. A securities fr...
CABA INVESTOR NOTICE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Cabaletta Bio, Inc. Investors with Losses to Secure...
NEW YORK, April 18, 2022 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant and/or traceable...
ROSEN, A RESPECTED AND TOP RANKED LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses Over $100K to Secure...
New York, New York--(Newsfile Corp. - April 17, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...
ROSEN, A LEADING LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Losses Over $100K to Secure Counsel Before I...
New York, New York--(Newsfile Corp. - April 16, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...
CABA SHAREHOLDER ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Cabaletta Bio, Inc. Investors with Loss...
New York, New York--(Newsfile Corp. - April 14, 2022) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Cabaletta Bio, Inc. (NASDAQ: CABA): (i) pursuant a...